Approval · Notice of Compliance 34156 · 2024
PLERIXAFOR INJECTION: Notice of Compliance 34156
Issued October 8, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34156
- Date
- October 8, 2024
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM). Update to package labels
- Canadian reference product
- MOZOBIL (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLERIXAFOR INJECTION | Not yet assigned | — |
Medicinal ingredients
- PLERIXAFOR 20 MG per ML